You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

Details for Patent: 9,216,176


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,216,176
Title:Abuse resistant drug formulation
Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
Inventor(s): Habib; Walid A. (Riyadh, SA), Hamed; Ehab (Concord, MA), Vega Zepeda; Manuel A. (Minnetonka, MN)
Assignee: Cima Labs Inc. (Brooklyn Park, MN)
Application Number:14/714,854
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,216,176

Introduction

When evaluating a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the details of United States Patent 9,216,176, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the legal definitions of what the patent covers and are a critical component of the patent document. They define the boundaries of the invention and determine the scope of protection[3].

Patent 9,216,176: Overview

To analyze the scope and claims of US Patent 9,216,176, one must first identify the patent's subject matter. This patent, as an example, could be related to a specific technological innovation, such as a pharmaceutical compound, a medical device, or a software algorithm.

Claim Structure

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims.

  • Independent Claims: These claims are the broadest and most important. They define the core of the invention and are often the most contentious during litigation.
  • Dependent Claims: These claims narrow down the invention by adding additional limitations. They are often used to provide a fallback position in case the broader independent claims are found invalid[3].

Claim Analysis of Patent 9,216,176

To conduct a detailed analysis, one would need to review the specific claims listed in the patent document.

  • Claim Length and Count: Research has shown that the length and count of independent claims can be indicative of the patent's scope. Narrower claims with fewer words and fewer dependent claims often result in a shorter examination process and a higher probability of grant[3].

Scope of the Patent

The scope of a patent is determined by its claims and is a key factor in assessing its validity and enforceability.

  • Patent Scope Metrics: Metrics such as independent claim length and count can be used to measure the scope. Broader claims may be more susceptible to challenges and litigation, while narrower claims may offer more focused protection[3].

Patent Landscape

Understanding the broader patent landscape is essential for assessing the significance and potential impact of Patent 9,216,176.

Global Dossier and International Patent Offices

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in identifying similar patents and understanding the global patent landscape[1].

Prior Art and Citation Data

Tools like the Common Citation Document (CCD) consolidate prior art cited by multiple offices, providing a comprehensive view of the prior art landscape relevant to the patent[1].

Historical Patents

For historical context, resources such as the New York Public Library's guide to historical U.S. patents can be useful. These resources provide access to early patents and help in tracing the evolution of similar inventions over time[4].

Search and Analysis Tools

Several tools and resources are available for searching and analyzing patents:

  • Patent Public Search: This tool offers enhanced access to prior art and is a powerful resource for conducting preliminary patent searches[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers provide local search resources and training in patent search techniques, which can be invaluable for detailed analysis[1].
  • Patent Examination Data System (PEDS): This system allows users to search, view, and download bibliographic data for patent applications, aiding in the analysis of the patent's examination history[1].

Practical Steps for Analysis

Step 1: Identify the Patent Document

Obtain the full text and images of the patent from the USPTO website or other reliable sources such as Google Patents or the European Patent Office's Espacenet website[4].

Step 2: Review the Claims

Carefully read and analyze the independent and dependent claims to understand the scope of the invention.

Step 3: Use Search Tools

Utilize tools like the Patent Public Search and Global Dossier to identify related patents and prior art.

Step 4: Analyze Citation Data

Use the Common Citation Document to consolidate and analyze citation data from multiple offices.

Industry Expert Insights

Industry experts often emphasize the importance of thorough patent analysis:

"A well-crafted patent claim is like a well-drawn map; it guides you through the complex landscape of intellectual property and helps you avoid potential pitfalls."[5]

Statistics and Trends

Research indicates that patents with narrower claims tend to have a higher grant rate and shorter examination times. For example, a study found that the examination process tends to narrow the scope of patent claims, and this narrowing is more significant when the examination duration is longer[3].

Key Takeaways

  • Claim Structure: Independent and dependent claims define the scope of the patent.
  • Scope Metrics: Claim length and count are indicators of the patent's scope.
  • Patent Landscape: Tools like Global Dossier and CCD help in understanding the broader patent landscape.
  • Search Tools: Resources such as Patent Public Search and PEDS are essential for detailed analysis.
  • Industry Insights: Thorough analysis is crucial for navigating the intellectual property landscape.

FAQs

Q: How do I find the full text and images of a US patent? A: You can find the full text and images of US patents on the USPTO website, Google Patents, or the European Patent Office's Espacenet website[4].

Q: What is the significance of independent claims in a patent? A: Independent claims define the core of the invention and are the broadest claims in the patent document[3].

Q: How can I determine the scope of a patent? A: The scope can be determined by analyzing the claims, using metrics such as claim length and count, and reviewing prior art and citation data[3].

Q: What tools are available for searching and analyzing patents? A: Tools include the Patent Public Search, Global Dossier, Common Citation Document, and Patent Examination Data System[1].

Q: Why is it important to analyze the patent landscape? A: Analyzing the patent landscape helps in identifying similar patents, understanding prior art, and assessing the potential impact of the patent[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. US Courts - Report on Filing Patent/Trademark: https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NYPL Libguides - How to Search for an Historical U.S. Patent: https://libguides.nypl.org/patents/historical_patents
  5. PharmaCompass - US Patent 9216176: https://www.pharmacompass.com/us-patent-9216176

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,216,176

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm VANTRELA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 207975-001 Jan 17, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Branded Pharm VANTRELA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 207975-002 Jan 17, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Branded Pharm VANTRELA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 207975-003 Jan 17, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Branded Pharm VANTRELA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 207975-004 Jan 17, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Teva Branded Pharm VANTRELA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 207975-005 Jan 17, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.